James C. Hamilton, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 10,000 shares at $64.19 ($642K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Scheduled sale ($642k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2025-10-03 | $700K | — | Filing → |
| ARWR | SELL | 2025-09-16 | $450K | — | Filing → |
| ARWR | SELL | 2025-09-04 | $375K | — | Filing → |